HeartCore Enterprises, Inc. (HTCR) - Dilution Analysis

Visualizing historical and potential share dilution over time

Dilution Analysis

High Risk
Significant dilution risk
Last updated: May 15, 2026

Risk Assessment Details

Potential Dilution: 96.13% of current shares
Recent Dilution: 33.83% (2 years)
Historical Dilution Factor: significant recent dilution
Outstanding Shares
1.4M
Potential Supply
1.4M
Additional shares possible
Splits
1 Split 1 Reverse
Past 2 years

Summary

HTCR currently has 1.44M outstanding shares. with significant dilution risk as 1.39M authorized shares could dilute existing holders by 96.1%. The company has significantly diluted shareholders by 33.83% over the past 2 years, indicating aggressive capital raising. Recent corporate actions include 1 stock split (positive for accessibility) and 1 reverse split (concerning signal).

Share Structure Timeline

Outstanding Shares
Total Supply

Historical Data Points

Date Event Outstanding Supply
May 15, 2026

10-Q filing | 1.4M shares outstanding

1.4M 1.4M
Apr 02, 2026
Stock Split

8-K filing: Stock split 1-for-20 | Outstanding: 25,459,388 → 1,272,969

1.3M 69K
Mar 31, 2026

10-K filing | 25.5M shares outstanding

25M 28M
Nov 18, 2025

10-Q filing | 23.3M shares outstanding

23M 28M
Aug 29, 2025

S-1/A filing: This prospectus relates to the resale by the selling stockholder named in this prospectus of (i) the offer and resale of up to 20,833,333 shares of our common stock by Crom Structured Opportunities Fund I, LP, that we may, in our discretion, elect to issue and sell to the Selling Stockholder, from time to time after the date of this prospectus, pursuant to an Equity Purchase Agreement we entered into with the Selling Stockholder on June 30, 2025, in which the Selling Stockholder has committed to purchase from us, at our direction, up to an aggregate of $25,000,000 of shares of our common stock (ii) 485,437 shares of our common stock issued to the Selling Stockholder as commitment shares (the "ELOC Commitment Shares") in connection with the Equity Purchase Agreement; (iii) up to 1,955,555 shares of our common stock issuable upon the conversion of 2,000 shares of the Company's Series A Convertible Preferred Stock issued to the Selling Stockholder pursuant to a Securities Purchase Agreement we entered into with the Selling Stockholder on June 30, 2025; and (iv) 750,000 shares of our common stock issued to the Selling Stockholder as commitment shares under the Securities Purchase Agreement.

23M 28M
Aug 13, 2025

10-Q filing | 22.1M shares outstanding

22M 3.7M
Jul 17, 2025

8-K filing: HeartCore Enterprises, Inc. issued 750,000 shares of common stock to Crom Structured Opportunities Fund I, LP as a commitment shares and 2,000 shares of Series A Convertible Preferred Stock for $2,000,000 on June 30, 2025. ($2.0M proceeds)

22M 3.7M
Jul 01, 2025

8-K filing: HeartCore Enterprises, Inc. entered into an Equity Purchase Agreement with Crom Structured Opportunities Fund I, LP, for the potential sale of up to $25,000,000 in shares of the Company's Common Stock over a 24-month period and issued 750,000 shares of common stock and 2,000 shares of Series A Convertible Preferred Stock in a Securities Purchase Agreement. ($2.0M proceeds)

22M 3.7M
May 15, 2025

10-Q filing | 22.1M shares outstanding

22M 3.7M
Mar 31, 2025

10-K filing | 20.9M shares outstanding

21M 3.7M
Nov 14, 2024

10-Q filing | 20.9M shares outstanding

21M 3.7M
Aug 14, 2024

10-Q filing | 20.9M shares outstanding

21M 3.7M
May 15, 2024

10-Q filing | 20.9M shares outstanding

21M 3.7M
Apr 09, 2024

10-K filing | 20.4M shares outstanding

20M 3.7M
Feb 29, 2024

8-K filing: HeartCore Enterprises, Inc. entered into a Service Agreement with Jyo Co., Ltd., where Jyo will issue a warrant to the Company to acquire shares equal to 2% of Jyo's fully diluted share capital in return for support services.

21M 3.7M
Nov 13, 2023

10-Q filing | 20.8M shares outstanding

21M 3.7M
Oct 03, 2023

8-K filing: HeartCore Enterprises, Inc. entered into a Service Agreement with GATES GROUP Inc. where GATES will pay HeartCore $600,000 for Phase 1 and Phase 2 services. For Phase 3, HeartCore will receive a warrant to acquire shares equal to 3% of GATES' fully diluted share capital.

21M 3.7M
Aug 14, 2023

10-Q filing | 20.8M shares outstanding

21M 3.7M
May 22, 2023

10-Q filing | 19.1M shares outstanding

19M 3.7M
Apr 12, 2023

8-K filing: HeartCore Enterprises, Inc. entered into a Consulting and Services Agreement with RYojbaba Inc., where HeartCore will provide services including assistance with IPO preparations in exchange for cash and a warrant to acquire 3,000 shares of RYojbaba's common stock, representing 3% of RYojbaba's issued and outstanding common stock.

21M 3.7M
Apr 07, 2023

S-3/A filing: Heartcore Enterprises, Inc. may offer and sell, from time to time in one or more offerings, shares of common stock, preferred stock, warrants, rights, debt securities and units up to a total dollar amount of $100,000,000.

21M 3.7M
Mar 31, 2023

10-K filing | 20.8M shares outstanding

21M 3.7M
Mar 28, 2023

8-K filing: HeartCore Enterprises, Inc. issued 500,000 shares of common stock to Prakash Sadasivam in exchange for the termination of an amended and restated warrant to purchase 737,500 shares of the company's common stock.

20M 3.7M
Mar 16, 2023

8-K filing: HeartCore Enterprises, Inc. entered into consulting agreements with Libera Gaming Operations, Inc. and ICheck Co., Ltd., issuing warrants to acquire shares of their capital stock as compensation for services.

20M 3.7M
Mar 13, 2023

S-3 filing: Heartcore Enterprises, Inc. may offer and sell, from time to time in one or more offerings, common stock, preferred stock, warrants, rights, debt securities and units up to a total dollar amount of $100,000,000.

20M 3.7M
Feb 06, 2023

8-K filing: HeartCore Enterprises, Inc. amended the Share Exchange and Purchase Agreement with Sigmaways, Inc. to issue 2,000,000 shares of common stock and a warrant to acquire 1,900,000 shares of common stock to Prakash Sadasivam, along with a cash payment of $1,000,000, in exchange for Sigmaways shares.

18M 3.7M
Nov 23, 2022

8-K filing: HeartCore Enterprises, Inc. entered into a 9th Stock Acquisition Rights Allotment Agreement with SYLA Technologies Co., Ltd., Amendment No. 2 to a Consulting Agreement with SYLA, and a Consulting and Services Agreement with SBC Medical Group, Inc., which includes the issuance of a warrant to HeartCore.

18M 3.7M
Nov 14, 2022

10-Q filing | 17.8M shares outstanding

18M 3.7M
Oct 26, 2022

8-K filing: HeartCore Enterprises entered into a Consulting and Services Agreement with Metros Development Co., Ltd., issuing warrants to acquire shares of Metros' capital stock as compensation for services, with subsequent amendments and termination of a similar agreement involving HeartCore Inc.

19M 3.7M
Sep 08, 2022

8-K filing: HeartCore Enterprises, Inc. entered into a Share Exchange and Purchase Agreement to acquire 51% of Sigmaways, Inc. by issuing 2,000,000 shares of HeartCore's common stock, paying $1,000,000 in cash, and issuing a warrant to acquire 1,500,000 shares of HeartCore's common stock.

19M 3.7M
Aug 18, 2022

8-K filing: HeartCore Enterprises, Inc. entered into Amendment No. 1 to the Consulting Agreement with Syla Technologies Co., Ltd., where Syla issued a warrant to the Company to acquire 37,500 shares of SYLA's capital stock in lieu of a $150,000 cash payment.

19M 3.7M
Aug 12, 2022

10-Q filing | 18.9M shares outstanding

19M 3.7M
May 16, 2022

10-Q filing | 17.3M shares outstanding

17M 3.7M
Apr 06, 2022

8-K filing: HeartCore Enterprises, Inc. entered into a Consulting and Services Agreement with Moveaction Co., Ltd., where HeartCore will provide services including assistance with Moveaction's potential IPO, and Moveaction will compensate HeartCore with cash and a warrant to purchase eight shares of Moveaction common stock at $0.01 per share after Moveaction's IPO.

19M 3.7M
Mar 31, 2022

10-K filing | 18.9M shares outstanding

19M 3.7M
Mar 02, 2022

8-K filing: HeartCore Enterprises purchased 278 shares of HeartCore Co. from Dentsu Digital for approximately $435,500, making HeartCore Co. a wholly-owned subsidiary. ($0.44M proceeds)

16M 3.7M
Feb 14, 2022

8-K filing: Issuance of common stock to executives as part of their employment agreements.

16M 3.7M
Feb 14, 2022

8-K filing: HeartCore Enterprises, Inc. closed its initial public offering on February 14, 2022, selling 3,000,000 shares of common stock at $5.00 per share, and issued a warrant to purchase up to an aggregate of 210,000 shares of Common Stock. ($15.0M proceeds)

16M 3.7M
Feb 08, 2022

S-1/A filing: HeartCore Enterprises, Inc. is offering 3,000,000 shares of common stock in an initial public offering, with an expected price range between $4.00 and $6.00 per share, and also registering the issuance of warrants to purchase 241,500 shares of common stock to the underwriters.

16M 3.7M
Jan 25, 2022

S-1/A filing: This S-1/A filing details HeartCore Enterprises' offering of 3,000,000 shares of common stock with an expected price between $4.00 and $6.00, along with representative's warrants to purchase 241,500 shares exercisable at $6.25, with the closing of the offering contingent upon Nasdaq listing approval.

16M 3.2M
Jan 03, 2022

S-1 filing: HeartCore Enterprises, Inc. is offering 2,500,000 shares of common stock in an initial public offering, with an expected price range between $5.00 and $7.00 per share, and is also registering the issuance of warrants to purchase 201,250 shares of common stock to the underwriters.

16M 2.7M
Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam Unsubscribe anytime